Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1062
  • 1063
  • 1064
  • …
  • ›
  • »

2026-07-30

Knightscope, Inc. Announces Second Quarter 2026 Earnings Conference Call

2026-07-30

Universal Display Corporation Announces Second Quarter 2026 Financial Results

2026-07-30

Aqua Metals Reports Second Quarter 2026 Results and Advances Phased Commercialization Plan for Headwaters ARC

2026-07-30

SPS Commerce Reports Strong Second Quarter 2026 Financial Results

2026-07-30

Navios Maritime Partners L.P. Announces Cash Distribution of $0.06 per Unit

2026-07-30

Schneider National, Inc. Announces Second Quarter 2026 Results

2026-07-30

Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call

2026-07-30

ACCO Brands Reports Second Quarter Results

2026-07-30

Hercules Capital Reports Second Quarter 2026 Financial Results

2026-07-30

Universal Electronics Inc. to Host Second Quarter 2026 Financial Results Conference Call on August 6th

2026-07-30

Jefferies strongly resets Ford stock target

2026-07-30

Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer

  • «
  • ‹
  • …
  • 1062
  • 1063
  • 1064
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies